21 December 2023

~1 minutes read

Galway MedTech company receive €1.5 million for device for late-stage cancer patients

Share story:
Galway MedTech company receive €1.5 million for device for late-stage cancer patients

A Galway Medtech company has received one point five million euro in a seeded funding round for a device for late-stage cancer patients.

SymPhysis Medical produce a device called ‘rel-eaze’ which deals with fluid in the chest and helps late-stage cancer patients to manage the condition independently.

The money will also support team growth, new jobs in research and development, product engineering and commericalisation and product engineering.

The company will seek an additional four point five million to support the continued development of the device early next year.

Share story:

Claims traffic lights in Loughrea are better when out-of-order

Claims are being made that Loughrea is better off with a set of traffic lights being out of order. The sequence of the lights at the West Bridge was chang...

Galway RNLI volunteer crew launches twice in 18- hour-period

The crew of the Galway RNLI lifeboat has launched twice in an 18- hour-period It launched on Sunday afternoon after a report of a windsurfer in difficulty...

Open discussion on a sustainable transport system for Galway

An open discussion on developing a sustainable transport system for Galway is to take place at the University of Galway tomorrow week This free-to-attend ...

Preliminary design completed for zebra crossing to facilitate university crossing at Salmon Weir

The preliminary design has been completed for a pedestrian crossing which will facilitate students in using the new Salmon Weir bridge to access the Unive...